by Rhoda Wilson, All News Pipeline: Pfizer’s vaccine for RSV is another among hundreds of novel biotechnology vaccines currently under development for a range of diseases that have gained approval from the US Food and Drug Administration. RSV of a common respiratory illness that usually causes mild cold-like symptoms, yet the vaccine industry wants to […]
Source